financetom
Business
financetom
/
Business
/
AtlasClear Gets $20 Million Financing; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AtlasClear Gets $20 Million Financing; Shares Rise
Oct 9, 2025 7:07 AM

09:41 AM EDT, 10/09/2025 (MT Newswires) -- AtlasClear ( ATCH ) said Thursday it has signed definitive agreements for a $20 million financing.

The company said Funicular Funds has led a reinvestment into AtlasClear ( ATCH ) as part of the $20 million financing, which includes the rollover of $4.25 million of a recent debt financing and participation from Sixth Borough Capital.

After the rollover, the financing will generate gross proceeds to AtlasClear ( ATCH ) of $15.75 million, before placement agent fees and other deal expenses, the company said.

AtlasClear ( ATCH ) said $10 million will be invested via convertible debt with a five-year term at an 11% coupon and a conversion price of $0.75, and an additional $10 million, inclusive of the $4.25 million converted from the debt financing, will be invested in the form of units sold at $0.60 per unit, comprising one share and one warrant with a strike price of $0.75.

AtlasClear ( ATCH ) shares were up 30% in recent trading.

Price: 0.46, Change: +0.10, Percent Change: +27.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
High Tide up 5.5% in U.S. Pre-market, Acquires Majority Stake in German Wholesaler Purecan
High Tide up 5.5% in U.S. Pre-market, Acquires Majority Stake in German Wholesaler Purecan
Jan 13, 2025
07:13 AM EST, 01/13/2025 (MT Newswires) -- High Tide (HITI.V), up 5.5% in U.S. pre-market trading, on Monday said it will acquire 51% of Purecan, a German pharmaceutical wholesaler, for 4.8 million euros in cash and shares. Purecan holds a license to import medical cannabis into Germany and is preparing to launch a telemedicine portal for medical cannabis patients in...
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
Jan 13, 2025
(Reuters) - Abercrombie & Fitch ( ANF ) on Monday raised its annual net sales growth target for the current quarter helped by strong demand for its apparel collections during the holiday shopping season. The company now expects fourth-quarter net sales to grow between 7% and 8%, compared with the prior target of 5% to 7% growth. (Reporting by Juveria...
Africa Oil Raises Stake in Orange Basin Block 3B/4B to 18%, Releases Share Buyback Program Results
Africa Oil Raises Stake in Orange Basin Block 3B/4B to 18%, Releases Share Buyback Program Results
Jan 13, 2025
07:08 AM EST, 01/13/2025 (MT Newswires) -- Africa Oil ( AOIFF ) on Monday said it increased its direct interest in Block 3B/4B offshore South Africa to 18%. The block, operated by TotalEnergies, lies to the southeast and on trend with a number of Orange Basin oil discoveries. The company and its subsidiary Africa Oil SA have completed a transaction...
Regeneron Pharmaceuticals' Trial Shows Adjuvant Libtayo Improved Disease-Free Survival After Surgery in CSCC Patients
Regeneron Pharmaceuticals' Trial Shows Adjuvant Libtayo Improved Disease-Free Survival After Surgery in CSCC Patients
Jan 13, 2025
07:12 AM EST, 01/13/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Monday that the phase 3 C-POST trial showed adjuvant treatment with Libtayo led to a statistically significant and clinically meaningful improvement in the primary endpoint of disease-free survival in patients with high-risk cutaneous squamous cell carcinoma after surgery. Libtayo demonstrated a 68% reduction in the risk of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved